Strep Infections Surged This Winter

21 Apr 2023
Qualified Infectious Disease Product
THURSDAY, April 20, 2023 – This past winter delivered a surge in strep infections, including more serious cases, a new analysis shows.
After two years of very low levels of strep infections during the pandemic, the number of strep infections is now almost 30% higher than the most recent peak, which was in 2017, the report found.
Still, “It is too early to definitively characterize this season since we are still in the middle of it,” the U.S. Centers for Disease Control and Prevention told CNN.
Epic Health Research Network, which conducted the analysis, said the spike in infections appeared to continue into early March, according to preliminary data from the electronic health records for more than 100 million people from thousands of clinics and hospitals.
Among the infections Group A Streptococcus bacteria can cause are strep throat and scarlet fever. These can typically be treated with antibiotics, but there is an ongoing shortage of the most common antibiotic for these infections, liquid amoxicillin, CNN reported.
More concerning is the invasive group A strep infection, which the CDC said it was investigating in December.
These “infections remain rare, especially in children,” the CDC added.
Strep infections are most common in children ages 5 to 15, according to the CDC. The usual strep season is December through April. The analysis found increases across ages, races, geographic regions and socioeconomic status.
Sources
CNN
Posted April 2023
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
-
Targets
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.